DJYG
ABBV icon

David J. Yvars Group’s AbbVie ABBV Stock Holding History

David J. Yvars Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-35,325
Closed -$5.71M – 80
2022
Q4 		$5.71M Sell
35,325
-2,346
-6% -$360K 7.15% 3
2022
Q3 		$5.06M Sell
37,671
-841
-2% -$121K 5.62% 4
2022
Q2 		$5.92M Sell
38,512
-1,703
-4% -$260K 8.06% 3
2022
Q1 		$6.52M Buy
+40,215
New +$5.84M 4.54% 3

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

David J. Yvars Group's ABBV Position: Q1 2023 in Review

David J. Yvars Group sold out of AbbVie (ABBV) in Q1 2023, closing a stake of 35,325 shares — an estimated $5.71M sold.

David J. Yvars Group first reported a position in ABBV in Q1 2022 and held it in 4 quarters. The position peaked at $6.52M in Q1 2022. 3,138 funds tracked by Wall St. Rank hold ABBV as of Q1 2023.

  • David J. Yvars Group reported no remaining AbbVie position as of Q1 2023 after selling out during the quarter.
  • David J. Yvars Group sold 35,325 AbbVie shares in Q1 2023, an estimated $5.71M.
  • David J. Yvars Group first reported a position in AbbVie in Q1 2022 and held it in 4 quarters.
  • David J. Yvars Group's AbbVie position peaked at $6.52M in Q1 2022.
  • 3,138 funds tracked by Wall St. Rank held AbbVie as of Q1 2023.

Based on David J. Yvars Group's 13F filing for Q1 2023, filed 20 Apr 2023.